NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 118 filers reported holding NUVATION BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $29,617,261 | +8.0% | 10,142,898 | +34.6% | 0.00% | 0.0% |
| Q1 2024 | $27,424,299 | +148.3% | 7,534,148 | +3.0% | 0.00% | – |
| Q4 2023 | $11,045,069 | +13.0% | 7,314,615 | +0.3% | 0.00% | – |
| Q3 2023 | $9,776,851 | -25.4% | 7,296,158 | +0.2% | 0.00% | – |
| Q2 2023 | $13,102,272 | +9.6% | 7,279,040 | +1.1% | 0.00% | – |
| Q1 2023 | $11,956,094 | -37.3% | 7,202,466 | -27.5% | 0.00% | -100.0% |
| Q4 2022 | $19,070,288 | -32.7% | 9,932,441 | -21.4% | 0.00% | 0.0% |
| Q3 2022 | $28,324,000 | -30.8% | 12,644,451 | +0.1% | 0.00% | 0.0% |
| Q2 2022 | $40,930,000 | -39.8% | 12,632,638 | -2.3% | 0.00% | -50.0% |
| Q1 2022 | $68,025,000 | -28.9% | 12,932,460 | +14.8% | 0.00% | 0.0% |
| Q4 2021 | $95,715,000 | -19.1% | 11,260,552 | -5.4% | 0.00% | -33.3% |
| Q3 2021 | $118,311,000 | +14.5% | 11,902,527 | +7.3% | 0.00% | 0.0% |
| Q2 2021 | $103,307,000 | +42.1% | 11,096,361 | +59.5% | 0.00% | +50.0% |
| Q1 2021 | $72,702,000 | – | 6,957,156 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 15,247,340 | $49,401,000 | 15.77% |
| Aisling Capital Management LP | 2,541,009 | $8,233,000 | 5.87% |
| EDBI Pte Ltd | 1,270,504 | $4,116,000 | 3.82% |
| Ally Bridge Group (NY) LLC | 1,137,152 | $3,684,000 | 3.36% |
| Deep Track Capital, LP | 11,471,281 | $37,167,000 | 2.44% |
| EcoR1 Capital, LLC | 13,896,543 | $45,025,000 | 1.55% |
| Boxer Capital, LLC | 4,341,009 | $14,065,000 | 0.89% |
| Baupost Group | 10,418,194 | $33,755,000 | 0.50% |
| Redmile Group, LLC | 3,471,709 | $11,248,000 | 0.43% |
| 683 Capital Management, LLC | 1,766,657 | $5,724,000 | 0.40% |